197 related articles for article (PubMed ID: 15639189)
1. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
Lee HH
Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
[TBL] [Abstract][Full Text] [Related]
2. Diversity of the CYP21P-like gene in CYP21 deficiency.
Lee HH
DNA Cell Biol; 2005 Jan; 24(1):1-9. PubMed ID: 15684714
[TBL] [Abstract][Full Text] [Related]
3. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module.
Lee HH; Lee YJ; Lin CY
Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125
[TBL] [Abstract][Full Text] [Related]
4. The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency.
Lee HH
J Hum Genet; 2004; 49(2):65-72. PubMed ID: 14730433
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
[TBL] [Abstract][Full Text] [Related]
6. An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis.
Rupert KL; Rennebohm RM; Yu CY
Exp Clin Immunogenet; 1999; 16(2):81-97. PubMed ID: 10343159
[TBL] [Abstract][Full Text] [Related]
7. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
Fanis P; Skordis N; Phylactou LA; Neocleous V
Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
[TBL] [Abstract][Full Text] [Related]
8. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
[TBL] [Abstract][Full Text] [Related]
9. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome.
Marino R; Moresco A; Perez Garrido N; Ramirez P; Belgorosky A
Front Endocrinol (Lausanne); 2022; 13():803226. PubMed ID: 35282436
[TBL] [Abstract][Full Text] [Related]
10. Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations.
Yang Z; Mendoza AR; Welch TR; Zipf WB; Yu CY
J Biol Chem; 1999 Apr; 274(17):12147-56. PubMed ID: 10207042
[TBL] [Abstract][Full Text] [Related]
11. Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia.
Morissette R; Chen W; Perritt AF; Dreiling JL; Arai AE; Sachdev V; Hannoush H; Mallappa A; Xu Z; McDonnell NB; Quezado M; Merke DP
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1143-52. PubMed ID: 26075496
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency.
Lee HH; Niu DM; Lin RW; Chan P; Lin CY
J Hum Genet; 2002; 47(10):517-22. PubMed ID: 12376740
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X.
Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP
BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125
[TBL] [Abstract][Full Text] [Related]
14. An unequal crossover event in RCCX modules of the human MHC resulting in the formation of a TNXB/TNXA hybrid and deletion of the CYP21A.
Jaatinen T; Chung EK; Ruuskanen O; Lokki ML
Hum Immunol; 2002 Aug; 63(8):683-9. PubMed ID: 12121677
[TBL] [Abstract][Full Text] [Related]
15. Mutation of IVS2 -12A/C>G in combination with 707-714delGAGACTAC in the CYP21 gene is caused by deletion of the C4-CYP21 repeat module with steroid 21-hydroxylase deficiency.
Lee HH; Chang SF; Tsai FJ; Tsai LP; Lin CY
J Clin Endocrinol Metab; 2003 Jun; 88(6):2726-9. PubMed ID: 12788880
[TBL] [Abstract][Full Text] [Related]
16. CYP21 and CYP21P variability in steroid 21-hydroxylase deficiency patients and in the general population in the Netherlands.
Koppens PF; Hoogenboezem T; Degenhart HJ
Eur J Hum Genet; 2000 Nov; 8(11):827-36. PubMed ID: 11093272
[TBL] [Abstract][Full Text] [Related]
17. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.
Carrozza C; Foca L; De Paolis E; Concolino P
Front Endocrinol (Lausanne); 2021; 12():709758. PubMed ID: 34394006
[TBL] [Abstract][Full Text] [Related]
18. Pseudogene
Lao Q; Zhou K; Parker M; Faucz FR; Merke DP
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833192
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.
Lao Q; Brookner B; Merke DP
J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653
[TBL] [Abstract][Full Text] [Related]
20. Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.
Chen W; Perritt AF; Morissette R; Dreiling JL; Bohn MF; Mallappa A; Xu Z; Quezado M; Merke DP
Hum Mutat; 2016 Sep; 37(9):893-7. PubMed ID: 27297501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
